Royal Biologics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
3
- Investments
-
2
Royal Biologics General Information
Description
Manufacturer and distributor of medical devices intended to use enhanced autologous healing technology (EAHT) to treat a broad range of musculoskeletal and regenerative medicine needs. The company offers branded and licensed ortho biologics, stem cell therapy devices and multiple spinal implant hardware product lines as well as focuses on the research, development and advancement of novel solutions, thereby promoting healing in a wide range of clinical settings.
Contact Information
Website
www.royalbiologics.comCorporate Office
- 401 Hackensack Avenue
- Suite 604
- Hackensack, NJ 07601
- United States
Corporate Office
- 401 Hackensack Avenue
- Suite 604
- Hackensack, NJ 07601
- United States
Royal Biologics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Royal Biologics Patents
Royal Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250073374-A1 | Systems and methods of enhancements of therapeutic properties of a solid graft material | Pending | 06-Sep-2023 | ||
| US-20230096096-A1 | Marrow aspiration device and method of use | Inactive | 27-Sep-2021 | ||
| AU-2016359598-A1 | Methods and apparatus for separating fluid components | Active | 24-Nov-2015 | ||
| AU-2016359598-B2 | Methods and apparatus for separating fluid components | Active | 24-Nov-2015 | ||
| AU-2022200087-A1 | Methods and apparatus for separating fluid components | Inactive | 24-Nov-2015 | A61M1/02 |
Royal Biologics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Royal Biologics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Royal Biologics Investments (2)
Royal Biologics’s most recent deal was a Later Stage VC with Coldplasmatech for . The deal was made on 25-Feb-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Coldplasmatech | 25-Feb-2025 | Later Stage VC | Other Devices and Supplies | ||
| FIBRINET | 01-Sep-2020 | Buyout/LBO | Biotechnology |
Royal Biologics FAQs
-
When was Royal Biologics founded?
Royal Biologics was founded in 2015.
-
Where is Royal Biologics headquartered?
Royal Biologics is headquartered in Hackensack, NJ.
-
What is the size of Royal Biologics?
Royal Biologics has 29 total employees.
-
What industry is Royal Biologics in?
Royal Biologics’s primary industry is Medical Supplies.
-
Is Royal Biologics a private or public company?
Royal Biologics is a Private company.
-
What is Royal Biologics’s current revenue?
The current revenue for Royal Biologics is .
-
How much funding has Royal Biologics raised over time?
Royal Biologics has raised $7.5M.
-
Who are Royal Biologics’s investors?
Granite Creek Capital Partners and have invested in Royal Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
